Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

Epidemiology of Mucormycosis in India

(2021) Hariprasath Prakash et al.   Microorganisms

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis

(2021) Teny M. John et al.   Journal of Fungi

COVID-19 Associated Pulmonary Aspergillosis

(2020) Andreas L.E. van Arkel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

(2020) Annemarie B Docherty et al.   BMJ-British Medical Journal

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

(2020) Alexandre Alanio et al.   Lancet Respiratory Medicine

Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study

(2020) Marco Falcone et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

(2019) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES